The probiotic potential of L. pentosus has been demonstrated in various in vitro studies, in animal models and even in clinical trials Its main properties include:
– Reduces cholesterol levels (25%) in in vitro tests
– Shows phytase activity (improves mineral bioavailability) in in vitro tests.
– Exhibits β-galactosidase activity in in vitro tests, thus aiding in lactose degradation.
– Inhibits growth of pathogens such as Listeria monocytogenes and Staphylococcus aureus in food packaging (biopreservative)
– Delays the onset of senescence (ageing) in animal models such as C. elegans.
– High anti-inflammatory activity in murine models.
– Reduces permeability and improves intestinal barrier integrity in murine models.
– Has successfully passed a PHASE 1 human clinical trial developed between IG-CSIC (www.ig.csic.es) and IMIBIC (www.imibic.org/fibico).